Assessment of a Radiomics-based Computer-Aided Diagnosis Tool for Pulmonary nodulES

Recruiting now · Not applicable

Conditions studied: Lung Cancer, Pulmonary Nodule, Solitary

In brief

This is a pragmatic clinical trial that will study the effect of a radiomics-based computer-aided diagnosis (CAD) tool on clinicians' management of pulmonary nodules (PNs) compared to usual care. Adults aged 35-89 years with 8-30mm PNs evaluated at Penn Medicine PN clinics will undergo 1:1 randomization to one of two groups, defined by the PN malignancy risk stratification strategy used by evaluating clinicians: 1) usual care or 2) usual care + use of a radiomics-based CAD tool.

Key facts

Study ID
NCT05968898
Run by
Abramson Cancer Center at Penn Medicine
People needed
300
Starts
2024-01-09
Expected to finish
2030-07-31
Last updated by the study team
2026-06-02

Who can join

Age: 35 and older, up to 89. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.